Citations for
1AMACR, MAGI2
MAGI-2 Is a Sensitive and Specific Marker of Prostatic Adenocarcinoma:  A Comparison With AMACR.
Goldstein J, Goyal R, Roland JT, Gellert LL, Clark PE, Hameed O, Giannico GA.
Am J Clin Pathol 146(3):294-302. doi: 10.1093/ajcp/aqw111. 2016
2AMACR
Global expression of AMACR transcripts predicts risk for prostate cancer - a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate.
Alinezhad S, Väänänen RM, Ochoa NT, Vertosick EA, Bjartell A, Boström PJ, Taimen P, Pettersson K.
BMC Urol 16:10. doi: 10.1186/s12894-016-0128-8. 2016
3AMACR
Phytol is lethal for Amacr-deficient mice.
Selkälä EM, Nair RR, Schmitz W, Kvist AP, Baes M, Hiltunen JK, Autio KJ.
Biochim Biophys Acta 1851(10):1394-405. doi: 10.1016/j.bbalip.2015.07.008. Epub 2015 Aug 4. 2015
4AMACR
AMACR amplification in myxofibrosarcomas: a mechanism of overexpression that promotes cell proliferation with therapeutic relevance.
Li CF, Fang FM, Lan J, Wang JW, Kung HJ, Chen LT, Chen TJ, Li SH, Wang YH, Tai HC, Yu SC, Huang HY.
Clin Cancer Res 20(23):6141-52. doi: 10.1158/1078-0432.CCR-14-1182. Epub 2014 Nov 10. 2014
5AMACR
α-Methylacyl-CoA racemase (AMACR) serves as a prognostic biomarker for the early recurrence/metastasis of HCC.
Xu B, Cai Z, Zeng Y, Chen L, Du X, Huang A, Liu X, Liu J.
J Clin Pathol 67(11):974-9. doi: 10.1136/jclinpath-2014-202378. Epub 2014 Aug 4. 2014
6AMACR
Value of α-methylacyl-CoA racemase immunochemistry for predicting neoplastic progression in Barrett's oesophagus.
Kastelein F, Biermann K, Steyerberg EW, Verheij J, Kalisvaart M, Looijenga LH, Stoop HA, Walter L, Kuipers EJ, Spaander MC, Bruno MJ; ProBar study group.
Histopathology 63(5):630-9. doi: 10.1111/his.12216. Epub 2013 Sep 5. 2013
7AMACR
Metabolic adaptation allows Amacr-deficient mice to remain symptom-free despite low levels of mature bile acids.
Selkälä EM, Kuusisto SM, Salonurmi T, Savolainen MJ, Jauhiainen M, Pirilä PL, Kvist AP, Conzelmann E, Schmitz W, Alexson SE, Kotti TJ, Hiltunen JK, Autio KJ.
Biochim Biophys Acta 1831(8):1335-43. doi: 10.1016/j.bbalip.2013.05.002. Epub 2013 May 13. 2013
8AMACR
Is there a role for prostate tumour overexpressed-1 in the diagnosis of HGPIN and of prostatic adenocarcinoma? A comparison with alpha-methylacyl CoA racemase.
Scarpelli M, Mazzucchelli R, Barbisan F, Santinelli A, Lopez-Beltran A, Cheng L, Montironi R.
Int J Immunopathol Pharmacol 25(1):67-74. 2012
9AMACR, AMACRD
AMACR mutations cause late-onset autosomal recessive cerebellar ataxia.
Dick D, Horvath R, Chinnery PF.
Neurology 76(20):1768-70. No abstract available. 2011
10AMACR
α-Methylacyl-CoA racemase spliced variants and their expression in normal and malignant prostate tissues.
Ouyang B, Leung YK, Wang V, Chung E, Levin L, Bracken B, Cheng L, Ho SM.
Urology 77(1):249.e1-7. doi: 10.1016/j.urology.2010.08.005. 2011
11AMACR, AMACRD
An adult onset case of alpha-methyl-acyl-CoA racemase deficiency.
Smith EH, Gavrilov DK, Oglesbee D, Freeman WD, Vavra MW, Matern D, Tortorelli S.
J Inherit Metab Dis 33 Suppl 3:S349-53. doi: 10.1007/s10545-010-9183-6. Epub 2010 Sep 4. 2010
12AMACR
Deletion hotspots in AMACR promoter CpG island are cis-regulatory elements controlling the gene expression in the colon.
Zhang X, Leav I, Revelo MP, Deka R, Medvedovic M, Jiang Z, Ho SM.
PLoS Genet 5(1):e1000334. Epub 2009 Jan 16. 2009
13AMACR
a-Methylacyl coenzyme A racemase is highly expressed in the intestinal-type adenocarcinoma and high-grade dysplasia lesions of the stomach.
Huang W, Zhao J, Li L, Huang Y, Yang X, Wang J, Zhang T.
Histol Histopathol 23(11):1315-20. 2008
14AMACR
Expression of alpha-methylacyl coenzyme A racemase in the dysplasia carcinoma sequence associated with Barrett's esophagus.
Scheil-Bertram S, Lorenz D, Ell C, Sheremet E, Fisseler-Eckhoff A.
Mod Pathol 21(8):961-7. Epub 2008 May 23. 2008
15AMACR, AMACRD
Relapsing encephalopathy in a patient with alpha-methylacyl-CoA racemase deficiency.
Thompson SA, Calvin J, Hogg S, Ferdinandusse S, Wanders RJ, Barker RA.
J Neurol Neurosurg Psychiatry 79(4):448-50. Epub 2007 Nov 21. 2008
16AMACR
The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase.
Wang J, Weng J, Cai Y, Penland R, Liu M, Ittmann M.
Prostate 66(8):847-57. 2006
17AMACR
A variant of the alpha-methyl-acyl-CoA racemase gene created by a deletion in exon 5 and its expression in prostate cancer.
Mubiru JN, Valente AJ, Troyer DA.
Prostate 65(2):117-23. 2005
18AMACR
The role of alpha-methylacyl-CoA racemase in bile acid synthesis.
Cuebas DA, Phillips C, Schmitz W, Conzelmann E, Novikov DK.
Biochem J 363(Pt 3):801-7. 2002
19AMACR, AMACRD
Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy.
Ferdinandusse S, Denis S, Clayton PT, Graham A, Rees JE, Allen JT, McLean BN, Brown AY, Vreken P, Waterham HR, Wanders RJ.
Nat Genet 24(2):188-91. 2000
20AMACR
Substrate stereospecificity in oxidation of (25S)-3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-cholestanoyl-CoA by peroxisomal trihydroxy-5 beta-cholestanoyl-CoA oxidase.
Pedersen JI, Veggan T, Bjorkhem I.
Biochem Biophys Res Commun 224(1):37-42 1996
21AMACR
Peroxisomal beta-oxidation of 2-methyl-branched acyl-CoA esters: stereospecific recognition of the 2S-methyl compounds by trihydroxycoprostanoyl-CoA oxidase and pristanoyl-CoA oxidase.
Van Veldhoven PP, Croes K, Asselberghs S, Herdewijn P, Mannaerts GP.
FEBS Lett 388(1):80-4 1996